Mangalam Drugs & Organics Ltd - 532637 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Mangalam Drugs & Organics has published a newspaper advertisement announcing a Postal Ballot and e-voting to obtain shareholder approval for a special business. The e-voting period is scheduled from May 19 to June 17, 2026, with results expected by June 19, 2026.
May 19 2026 17:13:38
Mangalam Drugs & Organics Ltd - 532637 - Board Meeting Outcome for Outcome Of Board Meeting Held On 14Th May, 2026 For Declaration Of Audited Financial Results(Standalone & Consolidated) Of The Company For The Quarter And Year Ended 31St ,March, 2026
Mangalam Drugs & Organics board approved audited FY26 cons. financial results, reporting revenue of ₹232.13 crores and a net loss of ₹44.40 crores. The NCLT hearing for the merger scheme with Mangalam Laboratories and Shri JB Pharma is set for June 2, 2026.
May 14 2026 17:45:40
Mangalam Drugs & Organics Ltd - 532637 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 14Th May, 2026 Inter-Alia To Approve Audited Financial Results(Standalone & Consolidated) Of The Company For The Period Ended 31St March, 2026
Mangalam Drugs & Organics board will meet on May 14, 2026, to consider and approve the audited financial results for the quarter and fiscal year ended March 31, 2026. This meeting will finalize the company's financial performance for the period.
May 06 2026 19:36:14
Read More